Jaguar Health (JAGX) Shares Outstanding (2020 - 2026)
Jaguar Health (JAGX) posted quarterly Shares Outstanding (Entity) of $515788.0 for Q1 2026, up 2578.31% year-over-year from $19258.0 in Q1 2025, and up 673.99% quarter-over-quarter from $66640.0 in Q4 2025.
Jaguar Health (JAGX) Shares Outstanding (2020 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Shares Outstanding (Entity) for 7 consecutive years, with $515788.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 2578.31% year-over-year to $515788.0; the TTM figure through Mar 2026 stood at $515788.0 (up 2578.31% YoY), while the FY2025 annual figure was $66640.0, up 691.92% from the prior year.
- Shares Outstanding (Entity) grew to $515788.0 in Q1 2026 per JAGX's latest filing, from $66640.0 in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $515788.0 in Q1 2026 and bottomed at $11.0 in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $41259.3 across 5 years, with a median of $2685.0 in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) changed 0.0% — and 2024, when it soared 3019.59%.
- Jaguar Health's Shares Outstanding (Entity) stood at $25.0 in 2022, then jumped by 1656.0% to $439.0 in 2023, then jumped by 1816.86% to $8415.0 in 2024, then jumped by 691.92% to $66640.0 in 2025, then soared by 673.99% to $515788.0 in 2026.
- Business Quant data shows JAGX's Shares Outstanding (Entity) at $515788.0 in Q1 2026, $66640.0 in Q4 2025, and $43234.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn | 515,788.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 515,788.00 |
| Dec 31, 2025 | 66,640.00 |
| Sep 30, 2025 | 43,234.00 |
| Jun 30, 2025 | 28,994.00 |
| Mar 31, 2025 | 17,904.00 |
| Dec 31, 2024 | 8,415.00 |
| Sep 30, 2024 | 10,709.00 |
| Jun 30, 2024 | 2,685.00 |
| Mar 31, 2024 | 3,026.00 |
| Dec 31, 2023 | 439.00 |
| Sep 30, 2023 | 395.00 |
| Jun 30, 2023 | 336.00 |
| Mar 31, 2023 | 97.00 |
| Dec 31, 2022 | 25.00 |
| Sep 30, 2022 | 27.00 |
| Jun 30, 2022 | 20.00 |
| Mar 31, 2022 | 11.00 |
| Dec 31, 2021 | 11.00 |
| Sep 30, 2021 | 12.00 |
| Jun 30, 2021 | 11.00 |